Yang, C., Xu, Y., Wang, O. (2026). Inetetamab combined with pyrotinib for neoadjuvant treatment of HER2-positive locally advanced breast cancer (neoPICD): A prospective, multicenter, single-arm phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.27